Akira Yuasa, Naohiro Yonemoto, Sven Demiya, Chihiro Foellscher, Shunya Ikeda
BACKGROUND: Health technology assessment (HTA) organizations play a crucial role in optimizing healthcare resources, but the factors influencing decision making vary by country. OBJECTIVE: HTAs of cancer and hepatitis C drugs were evaluated across developed countries to understand differences in decision processes and criteria. METHODS: The HTA organizations evaluated are from France, Germany, Italy, Spain, the United Kingdom (UK), Australia, Canada and Japan...
March 2021: PharmacoEconomics Open